These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 12708222)
1. Long-term cholinesterase inhibitor therapy for Alzheimer's disease: implications for long-term care. Brangman SA Am J Alzheimers Dis Other Demen; 2003; 18(2):79-84. PubMed ID: 12708222 [TBL] [Abstract][Full Text] [Related]
2. Donepezil can improve daily activities and promote rehabilitation for severe Alzheimer's patients in long-term care health facilities. Meguro K; Ouchi Y; Akanuma K; Meguro M; Kasai M BMC Neurol; 2014 Dec; 14():243. PubMed ID: 25516360 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Alzheimer's disease in the long-term-care setting. Smith DA Am J Health Syst Pharm; 2009 May; 66(10):899-907. PubMed ID: 19420308 [TBL] [Abstract][Full Text] [Related]
4. Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement. Wattmo C; Londos E; Minthon L Curr Alzheimer Res; 2018; 15(10):905-916. PubMed ID: 29732972 [TBL] [Abstract][Full Text] [Related]
5. Donepezil for dementia due to Alzheimer's disease. Birks JS; Harvey RJ Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184 [TBL] [Abstract][Full Text] [Related]
6. Donepezil use for advanced Alzheimer's disease--a case study from a long-term care facility. Tariot PN; Jakimovich L J Am Med Dir Assoc; 2003; 4(4):216-9. PubMed ID: 12837144 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990 [TBL] [Abstract][Full Text] [Related]
8. Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services. Wattmo C; Londos E; Minthon L Clin Interv Aging; 2014; 9():1951-62. PubMed ID: 25484578 [TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease: a prospective, observational study of factors affecting survival time from admission to death. Wattmo C; Londos E; Minthon L BMC Neurol; 2016 Aug; 16(1):156. PubMed ID: 27581368 [TBL] [Abstract][Full Text] [Related]
10. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention. Beier MT Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151 [TBL] [Abstract][Full Text] [Related]
11. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years. Wattmo C; Wallin ÅK Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660 [TBL] [Abstract][Full Text] [Related]
12. Care of individuals with Alzheimer's disease in the new millennium. Souder E; Rapp CG; Davis GV; Beck C; Liem PH Medsurg Nurs; 2004 Feb; 13(1):22-31. PubMed ID: 15029928 [TBL] [Abstract][Full Text] [Related]
14. A review of clinical treatment considerations of donepezil in severe Alzheimer's disease. Adlimoghaddam A; Neuendorff M; Roy B; Albensi BC CNS Neurosci Ther; 2018 Oct; 24(10):876-888. PubMed ID: 30058285 [TBL] [Abstract][Full Text] [Related]
16. A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil. Fullerton T; Binneman B; David W; Delnomdedieu M; Kupiec J; Lockwood P; Mancuso J; Miceli J; Bell J Alzheimers Res Ther; 2018 Apr; 10(1):38. PubMed ID: 29622037 [TBL] [Abstract][Full Text] [Related]
17. Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease. Green C; Picot J; Loveman E; Takeda A; Kirby J; Clegg A Pharmacoeconomics; 2005; 23(12):1271-82. PubMed ID: 16336020 [TBL] [Abstract][Full Text] [Related]
18. Effective pharmacological management of Alzheimer's disease. Atri A Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392 [TBL] [Abstract][Full Text] [Related]